133 related articles for article (PubMed ID: 23021046)
41. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.
Musette P; Bachelez H; Flageul B; Delarbre C; Kourilsky P; Dubertret L; Gachelin G
J Immunol; 1999 Feb; 162(3):1789-94. PubMed ID: 9973443
[TBL] [Abstract][Full Text] [Related]
42. Molecular diagnosis of a benign proliferative nodule developing in a congenital melanocytic nevus in a 3-month-old infant.
Murphy MJ; Jen M; Chang MW; Grant-Kels JM; Makkar H
J Am Acad Dermatol; 2008 Sep; 59(3):518-23. PubMed ID: 18640742
[TBL] [Abstract][Full Text] [Related]
43. Progress in melanoma histopathology and diagnosis.
Piris A; Mihm MC
Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
[TBL] [Abstract][Full Text] [Related]
44. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
45. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
46. Compound nevus with congenital features and balloon cell changes--an immunohistochemical study.
Cagnano E; Benharroch D; Sion-Vardy N
Ann Diagn Pathol; 2008 Oct; 12(5):362-4. PubMed ID: 18774500
[TBL] [Abstract][Full Text] [Related]
47. Angiotropic neonatal congenital melanocytic nevus: how extravascular migration of melanocytes may explain the development of congenital nevi.
Barnhill RL; Chastain MA; Jerdan MS; Lebbé C; Janin A; Lugassy C
Am J Dermatopathol; 2010 Jul; 32(5):495-9. PubMed ID: 20442637
[TBL] [Abstract][Full Text] [Related]
48. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
[No Abstract] [Full Text] [Related]
49. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
50. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
51. Current management approaches for congenital melanocytic nevi.
Krengel S; Marghoob AA
Dermatol Clin; 2012 Jul; 30(3):377-87. PubMed ID: 22800546
[TBL] [Abstract][Full Text] [Related]
52. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
53. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
54. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
[TBL] [Abstract][Full Text] [Related]
55. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
Collina G
Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
[No Abstract] [Full Text] [Related]
56. Make PEEC, not war: does evasive transdifferentiation protect from carcinogenesis?
Goerdt S
Med Hypotheses; 2001 Jul; 57(1):115-9. PubMed ID: 11421638
[TBL] [Abstract][Full Text] [Related]
57. The dysplastic nevus. Clinical and pathologic features.
Friedman RJ; Heilman ER; Rigel DS; Kopf AW
Dermatol Clin; 1985 Apr; 3(2):239-49. PubMed ID: 3830487
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
59. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
60. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
